ARDS | |||||||
---|---|---|---|---|---|---|---|
Control (n = 27) | Sepsis (n = 30) | All cases (n = 47) | Mild (n = 8) | Moderate (n = 14) | Severe (n = 25) | ||
Histological Patterns (%), median (range) | |||||||
Normal tissue | 100 (95–100) | 10 (0–55)A | 2.5 (0–50)A | 10 (0–50) | 0 (0–50)B | 2.5 (0–40)B | |
Exudative DAD | 0 | 57.5 (10–100)A | 60 (28–100)A | 55 (35–93) | 60 (28–100) | 60 (30–100) | |
Fibroproliferative DAD | 0 | 0 (0–40)A | 0 (0–45)A | 2.5 (0–10) | 2.5 (0–45) | 0 (0–45) | |
Bronchopneumonia | 0B | 0 (0–20) | 0 (0–48)B | 0 (0–25) | 0 (0–40) | 0 (0–48) | |
Scores, median (range) | |||||||
Septal thickening | 0 (0–1) | 1 (0–3)A | 2 (1–3)AB | 1 (0–3) | 1.5 (1–2)B | 2 (1–3)B | |
Oedema | 0 | 1.5 (1–3)A | 2 (0–3)A | 1 (1–3) | 2 (0–3) | 2 (1–3)B | |
Inflammation | 0 (0–1) | 1 (1–2)A | 2 (1–3)AB | 2 (1–2) | 2 (1–3)B | 2 (1–3)B | |
Hyaline Membrane | 0 | 1 (0–2)A | 1 (1–3)AB | 1 (1–3) | 1 (1–3)B | 2 (1–3)B | |
Alveolar Haemorrhage | 0 (0–1) | 1 (0–3)A | 1 (0–3)AB | 1 (0–3) | 1 (0–3) | 1 (0–3) | |
Proliferation of type II pneumocytes | 0 | 1 (0–2)A | 1 (0–3)A | 1.5 (0–3) | 2 (1–3) | 1 (1–3) | |
Inflammation pattern, n (%) | |||||||
Absent | 23 (85.5%) | 0 | 0 | 0 | 0 | 0 | |
Neutrophilic | 0 | 5 (16.7%) | 6 (12.8%) | 1 (12.5%) | 2 (14.3%) | 3 (12%) | |
Lymphomononuclear | 4 (14.8%) | 11 (36.7%) | 11 (23.4%) | 2 (25%) | 3 (21.4%) | 6 (24%) | |
Mixed | 0 | 14 (46.7%) | 30 (63.8%) | 5 (62.5%) | 9 (64.3%) | 16 (64%) |